Wednesday 29 July 2015, Amsterdam
The report recognizes the following companies as the key players in the PTCA Balloon Catheter Market in China: Abbott Laboratories, Boston Scientific Corp., Medtronic plc, MicroPort Scientific Corp. an dTerumo Corp.
Other Prominent Vendors in the market are: Aachen Resonance, Acrostak, AngioScore, Alvimedica, Asahi Intecc, Arthesys, Atrium Medical, B. Braun Melsungen, Biosensors International, BIOTRONIK, Cordis, Cook Medical, C.R. Bard, Goodman, Lepu Medical, Natec Medical, Smiths Medical, Tokai Medical Products and Volcano
Commenting on the report, an analyst said: “Physicians and patients are increasingly opting for minimally invasive surgeries in China. Advances in PTCA balloon catheters have led to an increased number of clinical trials and the launch of new products in the market.”
According to the report, the increased workload of the working class, an unhealthy diet, changing lifestyles, and physical inactivity raise blood pressure, blood glucose, and lipids, leading to obesity, hypertension, abnormal cholesterol, and diabetic problems.
Further, the report states that catheter-related bloodstream infections occur in individuals during the insertion of the peripheral catheter into the vein. Bacteria present on the skin are transferred along the catheter track and into the blood lumen, increasing the risk of infection in individuals.
ASDReports.com Media contact: S. Koopman -
Marketing and Communications
ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : email@example.com
back to News